[ad_1]
The antibody treatment that Donald Trump also followed also reached Iași. 3 patients from the Iași Infectious Diseases Hospital benefited from this treatment, which is currently in clinical trials.
And at Iași we conducted the study with this antibody concentrate, which is called REGENERON. Regeneron is a solution that contains antibodies that coat the virus and prevent it from settling in the cell, at the site of the receptors, and therefore multiplies ”, Carmen Dorobăț, director of the Hospital for Infectious Diseases of Iași, told Antena 3.
“So far we have used this treatment in 3 patients in the clinical trial. The good news is that the US Drug Enforcement Agency (FDA) has approved its use in the treatment of mild and moderate forms. Patient statements showed that They had no side effects and the general condition improved ”, he also specified.
“All the treatments used so far have been used by doctors in other diseases such as SARS-CoV-1 or Ebola”, explained, on Antena 3, Andreea Cigolea, director of the show “Sfat de Sănată”.
“This is the treatment with synthetic monoclonal antibodies, which acts directly on the peak protein and thus the virus no longer enters the cell. It is the treatment that Donald Trump also used when he was infected with SARS-CoV-2 and it seems that the results have Romanian doctors from the “Matei Balş” Institute and those from the Iași Infectious Diseases Hospital used this drug in tests and the results were exceptional. The patients healed much faster. “
He also stated that the difference between plasma and Regeneron treatment would be that the monoclonal antibodies in Regeneron are synthetic and those in plasma are natural. It appears that this would contribute to a much faster healing in patients receiving Regeneron.
According to doctors, the antibodies should be administered for the treatment of mild to moderate COVID-19 cases in adults, including people over 65, but also in children and adolescents.
The FDA has stated that the antibodies are not approved for hospitalized patients with COVID-19 or who require oxygen therapy.
Professor Adrian Streinu Cercel, who already uses it at the Matei Balş Institute, recently spoke about this treatment.
The method to stop the COVID pandemic in Romania would be the widespread use of monoclonal antibody treatment, said Professor Dr. Adrian Streinu Cercel, manager of the Matei Balş Institute in the capital, on Antena 3.
Prof. Cercel: Monoclonal antibodies, the solution to the pandemic
“I see there is no talk of monoclonal antibodies at all and they could be the way out of the pandemic. They are now in a very advanced stage of study and have a very important safety feature.
In addition, they manage to neutralize and control a possible infection for a period of six months.
If I were a decision-making body, I would move very quickly towards that solution, to make an administration as broad as possible and if we manage to control around 70% of the population, we would eliminate the virus from the circulation. “, Said Professor Dr. Adrian Streinu Cercel, in Antena 3.
[ad_2]
